What is he best known for?
The fields of study he is best known for:
Jinsong Liu mostly deals with Cancer research, Ovarian cancer, Cancer, Pathology and Ovarian carcinoma.
Jinsong Liu is studying Stromal cell, which is a component of Cancer research.
The Ovarian cancer study combines topics in areas such as Carcinogenesis, Oncogene, Immunology and Cell biology.
In general Cancer, his work in Cancer cell and Tumor progression is often linked to Molecular level linking many areas of study.
His work deals with themes such as Tissue microarray, Chemotherapy and Myosin, which intersect with Ovarian carcinoma.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology.
His most cited work include:
- The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. (989 citations)
- The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers (435 citations)
- Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis (388 citations)
What are the main themes of his work throughout his whole career to date?
Jinsong Liu mainly focuses on Cancer research, Ovarian cancer, Cancer, Pathology and Cancer cell.
His studies deal with areas such as Cell growth, Carcinogenesis, Immunology, Metastasis and Tumor progression as well as Cancer research.
His study looks at the intersection of Carcinogenesis and topics like Molecular biology with Gene expression and Tumor suppressor gene.
His Ovarian cancer study integrates concerns from other disciplines, such as Stromal cell, Oncogene and Oncology.
The study incorporates disciplines such as Adenocarcinoma and Ovary in addition to Pathology.
His studies examine the connections between Cancer cell and genetics, as well as such issues in Apoptosis, with regards to Kinase and Cell culture.
He most often published in these fields:
- Cancer research (50.50%)
- Ovarian cancer (43.48%)
- Cancer (29.43%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (50.50%)
- Ovarian cancer (43.48%)
- Cancer (29.43%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Ovarian cancer, Cancer, Cancer cell and Internal medicine.
His Cancer research research incorporates themes from Paclitaxel, Metastasis, Tumor suppressor gene, Tumor progression and In vivo.
Jinsong Liu studied Ovarian cancer and Cell growth that intersect with Apoptosis.
His work carried out in the field of Cancer brings together such families of science as Microvesicles and Stromal cell, Pathology.
His Cancer cell study incorporates themes from Endoreduplication, Cancer stem cell and Mitosis, Cell biology.
As part of one scientific family, Jinsong Liu deals mainly with the area of Internal medicine, narrowing it down to issues related to the Oncology, and often Serous ovarian cancer, Endometrial cancer, Subcutaneous tissue and Personalized therapy.
Between 2015 and 2021, his most popular works were:
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade (149 citations)
- Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system (128 citations)
- Platelets reduce anoikis and promote metastasis by activating YAP1 signaling (82 citations)
In his most recent research, the most cited papers focused on:
Jinsong Liu mainly investigates Cancer research, Cancer cell, Cancer, Ovarian cancer and Metastasis.
His research in Cancer research intersects with topics in Tumor necrosis factor alpha, Cytokine, Gene knockdown, NFKB1 and RHOA.
His Cancer cell research integrates issues from Endoreduplication, Molecular biology, Transcription factor and Cell biology.
His Cancer research incorporates elements of Serous fluid, Pathology and Interferon gamma.
Uterine cancer is closely connected to Apoptosis in his research, which is encompassed under the umbrella topic of Ovarian cancer.
His Metastasis research is multidisciplinary, relying on both Cancer stem cell, YAP1, microRNA, Disease and Tumor progression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
